Participants 144 182 7
patients with coronary artery disease.
Participants 287 529 6
Coronary artery disease patients whose LDL-C â‰¥ 70 mg/dL after treatment with atorvastatin 10 mg/day or rosuvastatin 2.5 mg/day were randomly assigned to receive ezetimibe 10 mg/day + statin (n = 78) or double-dose statin (n = 72) for 52 wee
